1. Home
  2. KRMD vs RDIB Comparison

KRMD vs RDIB Comparison

Compare KRMD & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$4.30

Market Cap

195.7M

Sector

Health Care

ML Signal

HOLD

RDIB

Reading International Inc Class B

N/A

Current Price

$9.89

Market Cap

224.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
KRMD
RDIB
Founded
1980
1937
Country
United States
United States
Employees
N/A
2025
Industry
Medical/Dental Instruments
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
195.7M
224.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRMD
RDIB
Price
$4.30
$9.89
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$6.50
N/A
AVG Volume (30 Days)
131.9K
3.7K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
$41,127,366.00
N/A
Revenue This Year
$20.32
N/A
Revenue Next Year
$17.38
$13.42
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$1.87
$7.61
52 Week High
$6.61
$17.40

Technical Indicators

Market Signals
Indicator
KRMD
RDIB
Relative Strength Index (RSI) 40.08 42.10
Support Level $4.08 $8.87
Resistance Level $4.34 $12.53
Average True Range (ATR) 0.18 0.52
MACD 0.02 -0.01
Stochastic Oscillator 43.24 55.38

Price Performance

Historical Comparison
KRMD
RDIB

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: